Additional file 1: of A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection

Multilingual abstracts in the five official working languages of the United Nations. (PDF 443 kb

Baseline characteristics of study participants.

†<p>Excluding women reporting prior tubal ligation or hysterectomy.</p>*<p>Fisher's exact test for categorical data and Wilcoxon two-sample test for continuous data.</p>ζ<p>Defined to participants as “someone who you have a regular relationship with.”</p><p>IQR: interquartile range.</p

Screening, enrollment, and pregnancy events in the CAPRISA 004 vaginal tenofovir gel trial.

<p>Screening, enrollment, and pregnancy events in the CAPRISA 004 vaginal tenofovir gel trial.</p

Covariates associated with adherence greater than 80% (use of 2 applicators with >80% of reported sex acts).

*<p>Time-updated covariate.</p><p>USD  =  U.S. Dollar.</p><p>95% CI  = 95% Confidence Interval.</p><p>N = 860 for unadjusted comparisons except “dislike something about gel” for which N = 731. N = 731 for the adjusted, multivariate model.</p

Participant characteristics.

<p>Participant characteristics.</p

HIV entry into various blood CD4+ T cell subsets.

<p>HIV entry into various blood CD4+ T cell subsets.</p

Adverse Effects March 2012-February 2013.

<p>Post-operative adverse effects for the second year of the VMMC pilot are shown ranked by grade. No intra-operative adverse effects were recorded.</p

Proportion of males testing HIV positive in pre-VMMC HCT by age group.

<p>Proportion of males testing HIV positive in pre-VMMC HCT by age group.</p

VMMCs performed by the CAPRISA VMMC program between March 2011 and February 2013.

<p>VMMCs performed by the CAPRISA clinic per month shown. No recruitment was undertaken in schools in November and December at the request of school officials to avoid disruption to examinations; recruitment was also not undertaken in the school holidays in January. Phase 1 of demand creation (community consultation) began in June 2010 and continued until April 2011. Phase 2 of demand creation (in-school information dissemination) was initiated from May 2011 to the end of February 2012. Phase 3 of demand creation (peer recruitment) began in March 2012 and continued until the February 2013.</p

Analysis of factors associated with mortality.

<p>Analysis of factors associated with mortality.</p